Loading...
XMADECR
Market cap337mUSD
Dec 20, Last price  
3.54EUR
1D
-0.28%
1Q
-4.32%
Jan 2017
92.39%
Name

Ercros SA

Chart & Performance

D1W1MN
XMAD:ECR chart
P/E
11.73
P/S
0.45
EPS
0.30
Div Yield, %
4.24%
Shrs. gr., 5y
-3.03%
Rev. gr., 5y
1.54%
Revenues
725m
-27.36%
213,920,000432,800,000774,410,000870,090,000866,490,000612,540,000609,280,000686,040,000677,530,000624,970,000603,670,000618,270,000602,540,000685,970,000671,940,000669,782,000568,797,000800,055,000998,532,000725,294,000
Net income
28m
-56.21%
-32,750,00038,500,0004,850,000-33,510,000-20,302,000,000-49,820,000-12,470,000-900,000-12,130,000-3,750,000-6,290,0007,240,00045,160,00044,582,00044,876,00031,043,0006,257,00043,297,00062,989,00027,585,000
CFO
51m
-18.81%
-15,510,000-650,000-14,540,00031,620,000-680,000,00040,910,000-10,580,00011,520,00019,170,00023,860,00028,050,00014,000,00038,950,00043,813,00044,876,00059,431,00074,591,00060,324,00062,989,00051,140,000
Dividend
Jul 08, 20240.096 EUR/sh
Earnings
Feb 25, 2025

Profile

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers. This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding powders, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing chipboards, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; plugs and switches in the electrical components sector; and household, sanitary, and packaging materials in the textile tanning industry. The Pharmacy division engages in the production of raw materials and intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, calcium and sodium fosfomycin, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.
IPO date
Sep 17, 1990
Employees
1,343
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
725,294
-27.36%
998,532
24.81%
800,055
40.66%
Cost of revenue
529,712
756,913
587,004
Unusual Expense (Income)
NOPBT
195,582
241,619
213,051
NOPBT Margin
26.97%
24.20%
26.63%
Operating Taxes
(23,764)
17,314
7,859
Tax Rate
7.17%
3.69%
NOPAT
219,346
224,305
205,192
Net income
27,585
-56.21%
62,989
45.48%
43,297
591.98%
Dividends
(13,715)
(8,211)
Dividend yield
5.55%
2.69%
Proceeds from repurchase of equity
(11,134)
(14,380)
(6,522)
BB yield
4.51%
4.71%
2.22%
Debt
Debt current
31,732
30,945
24,601
Long-term debt
108,777
116,806
101,627
Deferred revenue
13,334
12,802
10,997
Other long-term liabilities
19,686
23,080
12,893
Net debt
42,845
53,515
82,343
Cash flow
Cash from operating activities
51,140
62,989
60,324
CAPEX
(14,194)
(27,184)
(12,901)
Cash from investing activities
(33,835)
(52,814)
(34,238)
Cash from financing activities
(35,911)
(21,455)
(14,679)
FCF
229,759
191,883
174,042
Balance
Cash
39,145
55,480
50,305
Long term investments
58,519
38,756
(6,420)
Excess cash
61,399
44,309
3,882
Stockholders' equity
363,115
431,335
381,432
Invested Capital
465,985
483,364
467,254
ROIC
46.21%
47.19%
47.82%
ROCE
35.49%
43.88%
42.79%
EV
Common stock shares outstanding
93,587
94,229
98,781
Price
2.64
-18.52%
3.24
9.09%
2.97
38.14%
Market cap
247,070
-19.07%
305,303
4.06%
293,380
32.98%
EV
289,915
358,818
375,723
EBITDA
195,582
271,585
247,601
EV/EBITDA
1.48
1.32
1.52
Interest
9,793
3,787
3,794
Interest/NOPBT
5.01%
1.57%
1.78%